EMA Specifies New Warnings For Codeine/Ibuprofen Combination Drugs
A warning about the risk of severe hypokalemia and renal tubular acidosis is set to be added to the product information of fixed dose combinations of codeine and ibuprofen marketed in the EU following an investigation by the EMA's PRAC.
